KR880001098B1 - 헤모필루스 인플루엔재 b 다당류 엑소톡소이드 배합체 왁진의 제조방법 - Google Patents

헤모필루스 인플루엔재 b 다당류 엑소톡소이드 배합체 왁진의 제조방법 Download PDF

Info

Publication number
KR880001098B1
KR880001098B1 KR1019830003069A KR830003069A KR880001098B1 KR 880001098 B1 KR880001098 B1 KR 880001098B1 KR 1019830003069 A KR1019830003069 A KR 1019830003069A KR 830003069 A KR830003069 A KR 830003069A KR 880001098 B1 KR880001098 B1 KR 880001098B1
Authority
KR
South Korea
Prior art keywords
prp
polysaccharide
toxoid
protein
polysaccharides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019830003069A
Other languages
English (en)
Korean (ko)
Other versions
KR840005488A (ko
Inventor
고르던 랜스
Original Assignee
콘노트 러보러토리즈, 인코포레이티드
데이비드 윌리암스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 콘노트 러보러토리즈, 인코포레이티드, 데이비드 윌리암스 filed Critical 콘노트 러보러토리즈, 인코포레이티드
Publication of KR840005488A publication Critical patent/KR840005488A/ko
Application granted granted Critical
Publication of KR880001098B1 publication Critical patent/KR880001098B1/ko
Expired legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
KR1019830003069A 1982-07-06 1983-07-05 헤모필루스 인플루엔재 b 다당류 엑소톡소이드 배합체 왁진의 제조방법 Expired KR880001098B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/395,743 US4496538A (en) 1982-07-06 1982-07-06 Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US395743 1982-07-06

Publications (2)

Publication Number Publication Date
KR840005488A KR840005488A (ko) 1984-11-14
KR880001098B1 true KR880001098B1 (ko) 1988-06-29

Family

ID=23564316

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830003069A Expired KR880001098B1 (ko) 1982-07-06 1983-07-05 헤모필루스 인플루엔재 b 다당류 엑소톡소이드 배합체 왁진의 제조방법

Country Status (16)

Country Link
US (1) US4496538A (enExample)
EP (1) EP0098581B1 (enExample)
JP (2) JPS59501360A (enExample)
KR (1) KR880001098B1 (enExample)
AT (1) ATE19734T1 (enExample)
AU (1) AU561978B2 (enExample)
CA (1) CA1210695A (enExample)
DE (1) DE3363505D1 (enExample)
DK (1) DK161013C (enExample)
ES (1) ES8500745A1 (enExample)
FI (1) FI79024C (enExample)
IE (1) IE55268B1 (enExample)
IL (1) IL69165A (enExample)
NZ (1) NZ204771A (enExample)
WO (1) WO1984000300A1 (enExample)
ZA (1) ZA834939B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101427862B1 (ko) * 2009-12-17 2014-08-07 피나 바이오솔루션스, 엘엘씨 접합 백신 제조시 다당류를 활성화시키기 위한 화학 시약

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US5097020A (en) * 1983-07-05 1992-03-17 The University Of Rochester Immunogenic conjugates
US5360897A (en) * 1981-08-31 1994-11-01 The University Of Rochester Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4762713A (en) * 1983-07-05 1988-08-09 The University Of Rochester Boosting of immunogenic conjugate vaccinations by unconjugated bacterial capsular polymers
US4761283A (en) * 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
US4695624A (en) * 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
GB8421282D0 (en) * 1984-08-22 1984-09-26 Connaught Lab Multispecific antigenic proteins
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
IT1187753B (it) * 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
US5374426A (en) * 1986-09-03 1994-12-20 University Of Saskatchewan Rotavirus nucleocapsid protein VP6 in vaccine compositions
US5173294A (en) * 1986-11-18 1992-12-22 Research Foundation Of State University Of New York Dna probe for the identification of haemophilus influenzae
NZ223009A (en) * 1986-12-31 1990-06-26 Nl Rivm Of Thoven Oligosaccharides containing d-ribose d-ribitol and phosphate units mimicing haemophilus influenzae type b antigens
US5785973A (en) * 1988-02-01 1998-07-28 Praxis Biologics, Inc. Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines
CA2006587C (en) * 1988-12-23 2000-01-18 Robert W. Tolan Membrane proteins and peptides of haemophilus influenzae type b
EP0462210B1 (en) * 1989-03-09 1994-09-07 Praxis Biologics, Inc. Vaccines for nontypable haemophilus influenzae
EP0482068A1 (en) * 1989-07-14 1992-04-29 American Cyanamid Company Cytokine and hormone carriers for conjugate vaccines
GB8924473D0 (en) * 1989-10-31 1989-12-20 Connaught Lab Outer membrane protein p1 and peptides of haemophilus influenzae b
RU2105568C1 (ru) * 1989-12-14 1998-02-27 Нэшнл Рисерч Каунсл Оф Канада Полисахарид neisseria meningitidis с модифицированной группой b, конъюгированный антиген, вакцина против менингита группы b и способ индукции ответа антител к менингиту группы b
GR1001220B (el) * 1990-08-06 1993-06-21 Praxis Biolog Inc Φορεις κυτοκινης και ορμονης για συζευγμενα εμβολια.
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
US5476929A (en) * 1991-02-15 1995-12-19 Uab Research Foundation Structural gene of pneumococcal protein
JP3215109B2 (ja) * 1991-02-15 2001-10-02 ユーエイビー リサーチ ファウンデーション 肺炎球菌タンパクの構造遺伝子
US5965141A (en) * 1991-02-15 1999-10-12 Uab Research Foundation Epitopic regions of pneumococcal surface protein a
US5980909A (en) 1991-02-15 1999-11-09 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
KR950700081A (ko) * 1992-02-11 1995-01-16 W 로우 죤 이중 캐리어 면역원성 구성물
CA2105629A1 (en) * 1992-09-14 1994-03-15 Robert S. Becker Potentiation of immunogenic response
US5604108A (en) * 1992-09-14 1997-02-18 Connaught Laboratories, Inc. Test for determining the dose response of a conjugated vaccine
US5686078A (en) * 1992-09-14 1997-11-11 Connaught Laboratories, Inc. Primary and secondary immunization with different physio-chemical forms of antigen
US5955089A (en) 1993-04-20 1999-09-21 Uab Research Foundation Strain selection of pneumococcal surface proteins
US6361779B1 (en) 1993-11-08 2002-03-26 Aventis Pasteur Limited Transferrin receptor genes
US6358727B1 (en) * 1993-11-08 2002-03-19 Aventis Pasteur Limited Haemophilus transferrin receptor genes
AU699913B2 (en) * 1993-11-10 1998-12-17 Henry M. Jackson Foundation For The Advancement Of Military Medicine Compositions and method for stimulating antibody release by B lymphocytes
WO1996020012A2 (en) * 1994-12-23 1996-07-04 Middlesex Sciences, Inc. Methods for preparing and purifying macromolecular conjugates
KR100417183B1 (ko) * 1995-03-22 2004-05-31 헨리 엠. 잭슨 파운데이션 포 더 어드벤스먼트 오브 밀리터리 메디신 유기시아닐화제로활성화된가용성탄수화물을이용한면역원성구조체제조
EP0814833B1 (en) * 1995-03-22 2003-05-28 Henry M. Jackson Foundation For The Advancement Of Military Medicine Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
US5811102A (en) * 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines
US6432669B1 (en) 1998-10-07 2002-08-13 Aventis Pasteur Limited Protective recombinant Haemophilus influenzae high molecular weight proteins
US6342232B1 (en) 1999-03-03 2002-01-29 Aventis Pasteur Limited Multi-component vaccine comprising at least three antigens to protect against disease cased by Haemophilus influenzae
US6335182B1 (en) 1999-03-16 2002-01-01 Aventis Pasteur Limited Recombinant Haemophilus influenzae adhesin proteins
US7785609B1 (en) 1999-03-16 2010-08-31 Sanofi Pasteur Limited Recombinant Haemophilus influenzae adhesin proteins
US6391313B1 (en) 1999-07-15 2002-05-21 Aventis Pasteur Limited Multi-component vaccine to protect against disease caused by Haemophilus influenzae and Moraxella catarrhalis
WO2002020059A2 (en) 2000-09-01 2002-03-14 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Vibrio cholerae o139 conjugate vaccines
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
FI114275B (fi) * 2002-05-31 2004-09-15 Nokia Corp Taajuudenvälisten kanavavaihtojen hallinta
US7803386B2 (en) * 2003-06-05 2010-09-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli
CN1984679B (zh) * 2004-06-04 2013-05-15 美国政府健康及人类服务部 制备免疫原性结合物的方法
US7625736B2 (en) * 2004-06-04 2009-12-01 The United States Of America As Represented By The Department Of Health And Human Services Methods for preparing immunogenic conjugates
LT2144924T (lt) 2007-04-16 2016-10-10 Minervax Aps Sulieto baltymo vakcina
US9733663B2 (en) 2014-03-26 2017-08-15 Ethicon Llc Power management through segmented circuit and variable voltage protection
WO2017117539A1 (en) 2015-12-30 2017-07-06 Northwestern University Cell-free glycoprotein synthesis (cfgps) in prokaryotic cell lysates enriched with components for glycosylation
US10829795B2 (en) 2016-07-14 2020-11-10 Northwestern University Method for rapid in vitro synthesis of glycoproteins via recombinant production of N-glycosylated proteins in prokaryotic cell lysates
EP3323424A1 (en) 2016-11-17 2018-05-23 Cyanimal IP Cyaa polypeptides as immune enhancer
CA3052621A1 (en) 2017-02-03 2018-08-09 Schadeck, Eva Barbara Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
WO2019070994A1 (en) 2017-10-04 2019-04-11 Liffey Biotech Limited SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE
US11530432B2 (en) 2018-03-19 2022-12-20 Northwestern University Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates
US12404533B2 (en) 2019-01-11 2025-09-02 Northwestern University Bioconjugate vaccines' synthesis in prokaryotic cell lysates
US12226410B2 (en) 2019-10-18 2025-02-18 Northwestern University Methods for enhancing cellular clearance of pathological molecules via activation of the cellular protein ykt6
WO2021176409A1 (en) 2020-03-05 2021-09-10 Sanofi Healthcare India Private Limited Preservative combination for vaccine composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185090A (en) * 1972-02-02 1980-01-22 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
FR2407262A1 (fr) * 1977-10-27 1979-05-25 Cassenne Lab Sa Nouveaux polysaccharides extraits de corps microbiens d'haemophilus influenzae, procede de preparation et application a titre de medicaments de ces nouveaux produits
US4220717A (en) * 1977-12-22 1980-09-02 American Cyanamid Company Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
US4196192A (en) * 1977-10-28 1980-04-01 American Cyanamid Company Combined Haemophilus influenzae type b and pertussis vaccine
US4264764A (en) * 1979-01-12 1981-04-28 Merck & Co., Inc. Meningitis vaccine
US4307080A (en) * 1979-09-24 1981-12-22 Merck & Co., Inc. Meningitis vaccine
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101427862B1 (ko) * 2009-12-17 2014-08-07 피나 바이오솔루션스, 엘엘씨 접합 백신 제조시 다당류를 활성화시키기 위한 화학 시약

Also Published As

Publication number Publication date
KR840005488A (ko) 1984-11-14
ATE19734T1 (de) 1986-05-15
IE831574L (en) 1984-01-06
NZ204771A (en) 1987-03-06
ES523905A0 (es) 1984-11-01
US4496538A (en) 1985-01-29
AU561978B2 (en) 1987-05-21
ZA834939B (en) 1984-08-29
FI79024C (fi) 1989-11-10
CA1210695A (en) 1986-09-02
FI840874A7 (fi) 1984-03-05
IE55268B1 (en) 1990-07-18
EP0098581B1 (en) 1986-05-14
EP0098581A3 (en) 1984-02-15
WO1984000300A1 (en) 1984-02-02
FI79024B (fi) 1989-07-31
IL69165A0 (en) 1983-11-30
FI840874A0 (fi) 1984-03-05
DK93584A (da) 1984-02-23
JPS59501360A (ja) 1984-08-02
DK161013B (da) 1991-05-21
JPH0347253B2 (enExample) 1991-07-18
IL69165A (en) 1987-11-30
DE3363505D1 (de) 1986-06-19
DK161013C (da) 1991-10-28
JPH07121872B2 (ja) 1995-12-25
ES8500745A1 (es) 1984-11-01
EP0098581A2 (en) 1984-01-18
DK93584D0 (da) 1984-02-23
JPH05262668A (ja) 1993-10-12
AU1822783A (en) 1984-02-08

Similar Documents

Publication Publication Date Title
KR880001098B1 (ko) 헤모필루스 인플루엔재 b 다당류 엑소톡소이드 배합체 왁진의 제조방법
US4619828A (en) Polysaccharide exotoxoid conjugate vaccines
Schneerson et al. Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.
US4644059A (en) Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine
US4711779A (en) Glycoproteinic conjugates having trivalent immunogenic activity
KR100217317B1 (ko) 올리고당류와 운반 단백질의 공유결합 콘쥬게이트 및 그의 제조방법 및 그로써 제조된 왁진
EP0658118B1 (en) Vaccines against group c neisseria meningitidis
Finkelstein et al. Procholeragenoid: an aggregated intermediate in the formation of choleragenoid
EP0088303B1 (fr) Procédé de préparation de complexes polysaccharide-protéine de capsules bactériennes, produits obtenus et compositions immunogènes les contenant
US5192540A (en) Haemophilus influenzae type b oxidized polysaccharide-outer membrane protein conjugate vaccine
KR920014829A (ko) 뉴모코커스 다당류 결합체 백신
KR100404312B1 (ko) 폴리리보실리비톨포스페이트를함유한백신조성물과이들의제조방법
CS272759B2 (en) Method of lyophilized adsorbed multivalent vaccines preparation
Moreno et al. Immunity and protection of mice against Neisseria meningitidis group B by vaccination, using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide
EP0338265B1 (en) Haemophilus influenzae type B polysaccharide-outer membrane protein conjugate vaccine
Cryz Jr et al. Pseudomonas aeruginosa polysaccharide-tetanus toxoid conjugate vaccine: safety and immunogenicity in humans
IE42760B1 (en) Derivatives of the tetanus toxin, process for their preparation and agents containing them
Seid Jr et al. Chemical evidence for covalent linkages of a semisynthetic glycoconjugate vaccine for Haemophilus influenzae type b disease
Warren et al. Antigenicity of formaldehyde-inactivated staphylococcal enterotoxin B
NL8403195A (nl) Immunogene complexen en vaccins die deze bevatten.
EP0238739B1 (en) Klebsiella capsular polysaccharide vaccine
Monji et al. Isolation of the outer membrane components of Bordetella pertussis which enhance the immunogenicity of Haemophilus influenzae type b capsular polysaccharide polyribosyl ribitol phosphate
NO157603B (no) Fremgangsmÿte for fremstilling av et vannopplelig kovale nt polysakkarid difteri/toksoid konjugat samt et hapten, i det vesentlige fritt for protein og nukleinsyre.
Tully et al. Preparation, Characterization, and Antigenicity of a Saline Soluble Fraction From Shigella Types
Gotschlich Immune response to the meningococcal group-specific polysaccharides

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19830705

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19860402

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19830705

Comment text: Patent Application

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19880601

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19880908

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19881102

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19881102

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19910628

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19920714

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19930610

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 19940609

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 19950517

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 19960510

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 19970507

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 19980527

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 19990521

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20000531

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20010524

Start annual number: 14

End annual number: 14

PR1001 Payment of annual fee

Payment date: 20020521

Start annual number: 15

End annual number: 15

FPAY Annual fee payment

Payment date: 20030512

Year of fee payment: 16

PR1001 Payment of annual fee

Payment date: 20030512

Start annual number: 16

End annual number: 16

EXPY Expiration of term
PC1801 Expiration of term